Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -39,539 | -30,852 |
| Depreciation Amortization | 2,216 | 535 |
| Income taxes - deferred | 55 | 108 |
| Accounts receivable | -596 | N/A |
| Accounts payable and accrued liabilities | -279 | -1,325 |
| Other Working Capital | -5,793 | 2,381 |
| Other Operating Activity | 11,659 | 9,101 |
| Operating Cash Flow | $-32,276 | $-20,053 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -6,630 | -61 |
| Net Acquisitions | -1,000 | N/A |
| Investing Cash Flow | $-7,630 | $-61 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 6,694 | 4,445 |
| Common Stock Issued | 9,978 | 63,746 |
| Other Financing Activity | 0 | -1,382 |
| Financing Cash Flow | $16,672 | $66,808 |
| Exchange Rate Effect | 351 | -6 |
| Beginning Cash Position | 47,956 | 1,268 |
| End Cash Position | 25,072 | 47,956 |
| Net Cash Flow | $-22,884 | $46,689 |
| Free Cash Flow | ||
| Operating Cash Flow | -32,276 | -20,053 |
| Capital Expenditure | -6,630 | -61 |
| Free Cash Flow | -38,906 | -20,114 |